BioAge Labs (BIOA) Current Leases (2023 - 2026)
BioAge Labs' (BIOA) quarterly Current Leases came in at $714000.0 in Q2 2026, up 13.33% year-over-year from $630000.0 in Q2 2025, and up 10.53% quarter-over-quarter from $646000.0 in Q1 2026.
Powered by 
Analysis
BioAge Labs (BIOA) Current Leases (2023 - 2026) Analysis & Trends
BioAge Labs has disclosed Current Leases across 4 years of filings, most recently posting $714000.0 for Q2 2026.
- In Q2 2026, Current Leases rose 13.33% year-over-year to $714000.0; the TTM figure through Jun 2026 stood at $714000.0 (up 13.33% YoY), while the FY2025 annual figure was $582000.0, up 188.12% from the prior year.
- Current Leases came in at $714000.0 for Q2 2026 at BioAge Labs, up from $646000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $714000.0 in Q2 2026 to a low of $194000.0 in Q4 2023.
- Average Current Leases over 4 years is $502333.3, with a median of $582000.0 recorded in 2025.
- Year-over-year, Current Leases surged 188.12% in 2025 and retreated 7.71% in 2026.
- Over 4 years, Current Leases stood at $194000.0 in 2023, then grew by 4.12% to $202000.0 in 2024, then surged by 188.12% to $582000.0 in 2025, then grew by 22.68% to $714000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $714000.0 in Q2 2026, $646000.0 in Q1 2026, and $582000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 12.38 Mn |
| 10 | BioAge Labs | 409.83 Mn | 409.83 Mn | -14.23 Mn | 714,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 714,000.00 |
| Mar 31, 2026 | 646,000.00 |
| Dec 31, 2025 | 582,000.00 |
| Sep 30, 2025 | 580,000.00 |
| Jun 30, 2025 | 630,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 202,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Dec 31, 2023 | 194,000.00 |